Avadel Specialty Pharmaceuticals (Assets)
Buildings and Property
Avadel Specialty Pharmaceuticals (Assets) valuation and funding history | Last updated: April 15, 2019 | 1 funding rounds
Current Valuation
N/A
As of April 15, 2019
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO†
$250.0K
Last Funding
Apr 2019
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| April 15, 2019 | Buyout/LBO† | $250.0K | N/A | - |
Valuation Analysis
Current Valuation Metrics
Avadel Specialty Pharmaceuticals (Assets) is currently valued at N/A as of April 15, 2019.
Explore More Data
Detailed analysis for Avadel Specialty Pharmaceuticals (Assets)
What is Avadel Specialty Pharmaceuticals (Assets) Worth in 2026?
Avadel Specialty Pharmaceuticals (Assets) is a leading private company in the Buildings and Property sector. Track Avadel Specialty Pharmaceuticals (Assets)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Avadel Specialty Pharmaceuticals (Assets) Valuation is Determined
Private company valuations like Avadel Specialty Pharmaceuticals (Assets)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.